TROMBETTA, CLAUDIA MARIA
 Distribuzione geografica
Continente #
EU - Europa 7.333
NA - Nord America 6.311
AS - Asia 3.922
SA - Sud America 841
AF - Africa 201
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 3
Totale 18.618
Nazione #
US - Stati Uniti d'America 6.171
GB - Regno Unito 2.941
RU - Federazione Russa 1.384
SG - Singapore 1.234
CN - Cina 1.114
IT - Italia 968
BR - Brasile 699
IE - Irlanda 678
VN - Vietnam 556
HK - Hong Kong 342
FR - Francia 273
SE - Svezia 262
DE - Germania 233
KR - Corea 208
UA - Ucraina 180
FI - Finlandia 166
IN - India 136
ZA - Sudafrica 75
CA - Canada 63
AR - Argentina 59
BD - Bangladesh 50
MX - Messico 46
TR - Turchia 44
NL - Olanda 41
IQ - Iraq 40
PL - Polonia 39
CI - Costa d'Avorio 37
AT - Austria 35
ES - Italia 31
JP - Giappone 26
ID - Indonesia 24
BE - Belgio 22
MA - Marocco 21
EC - Ecuador 20
CO - Colombia 19
NG - Nigeria 19
KE - Kenya 18
PK - Pakistan 18
CZ - Repubblica Ceca 15
LT - Lituania 13
PH - Filippine 13
UZ - Uzbekistan 11
CL - Cile 10
SA - Arabia Saudita 10
VE - Venezuela 10
AE - Emirati Arabi Uniti 9
JO - Giordania 9
PE - Perù 9
AZ - Azerbaigian 8
EG - Egitto 8
PY - Paraguay 8
AL - Albania 7
IR - Iran 7
JM - Giamaica 7
OM - Oman 7
CR - Costa Rica 6
IL - Israele 6
LB - Libano 6
MY - Malesia 6
NP - Nepal 6
AU - Australia 5
CH - Svizzera 5
HU - Ungheria 5
RO - Romania 5
TN - Tunisia 5
DK - Danimarca 4
DZ - Algeria 4
ET - Etiopia 4
KG - Kirghizistan 4
KH - Cambogia 4
KZ - Kazakistan 4
LV - Lettonia 4
PA - Panama 4
UY - Uruguay 4
AM - Armenia 3
BG - Bulgaria 3
GR - Grecia 3
GT - Guatemala 3
HN - Honduras 3
MD - Moldavia 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BO - Bolivia 2
BY - Bielorussia 2
CG - Congo 2
DO - Repubblica Dominicana 2
EU - Europa 2
GA - Gabon 2
GE - Georgia 2
LA - Repubblica Popolare Democratica del Laos 2
MM - Myanmar 2
PS - Palestinian Territory 2
RS - Serbia 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
BB - Barbados 1
CY - Cipro 1
Totale 18.600
Città #
Southend 2.802
Dallas 1.224
Dublin 669
Singapore 648
Fairfield 452
Ashburn 419
Santa Clara 406
Moscow 375
Chandler 354
Hong Kong 322
Hefei 303
Siena 279
Beijing 259
Woodbridge 236
Seoul 208
Seattle 203
Houston 196
Council Bluffs 193
San Jose 165
Wilmington 163
Ho Chi Minh City 161
Ann Arbor 155
Jacksonville 141
Los Angeles 134
Cambridge 131
Dong Ket 113
Hanoi 110
The Dalles 98
Lauterbourg 94
Princeton 87
Helsinki 84
Munich 80
New York 66
Johannesburg 65
Rome 62
Milan 61
Lappeenranta 56
São Paulo 52
Florence 50
San Diego 48
Bengaluru 47
Buffalo 46
Orem 43
Nanjing 42
Shanghai 41
Boardman 40
San Mateo 39
Abidjan 37
Chicago 35
Redondo Beach 33
Warsaw 33
Nuremberg 32
Frankfurt am Main 30
London 26
Montreal 26
Dearborn 24
Baghdad 23
Tokyo 23
Rio de Janeiro 21
Stockholm 21
Brooklyn 20
Brussels 20
Da Nang 20
Denver 20
Livorno 20
Chennai 19
Haiphong 18
Vienna 18
Abuja 17
Guangzhou 17
Málaga 17
Nanchang 17
Shenyang 17
Toronto 17
Bari 16
Belo Horizonte 16
Phoenix 16
Brasília 15
Manchester 15
Portsmouth 14
Amsterdam 13
Brescia 13
Mexico City 13
Redwood City 13
San Francisco 13
Tianjin 13
Columbus 12
Dhaka 12
Hải Dương 12
Kunming 12
Mumbai 12
Porto Alegre 12
Turku 12
Izmir 11
Arezzo 10
Fremont 10
Washington 10
Atlanta 9
Bogotá 9
Charlotte 9
Totale 12.965
Nome #
"OKKIO alla salute 2014" results from the Tuscan sample 676
Epidemiology of herpes simplex virus type 1 and 2 in Italy: a seroprevalence study from 2000 to 2014 599
The virucidal potential effects of violet-blue light on influenza D virus 549
How to assess the effectiveness of nasal influenza vaccines? Role and measurement of sIgA in mucosal secretions 543
Elimination of congenital rubella: a seroprevalence study of pregnant women and women of childbearing age in Italy 477
Toxoplasma gondii in women of childbearing age and during pregnancy: seroprevalence study in Central and Southern Italy from 2013 to 2017 456
Pertussis over two decades: Seroepidemiological study in a large population of the Siena Province, Tuscany Region, Central Italy 406
Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2 343
Egg-Independent Influenza Vaccines and Vaccine Candidates 326
Influenza anti-stalk antibodies: Development of a new method for the evaluation of the immune responses to universal vaccine 291
Maraviroc as a potential HIV-1 latency-reversing agent in cell line models and ex vivo CD4 T cells 281
Challenges in the development of egg-independent vaccines for influenza 267
Emerging influenza strains in the last two decades: A threat of a new pandemic? 256
Comparison of hemagglutination inhibition, single radial hemolysis, virus neutralization assays, and ELISA to detect antibody levels against seasonal influenza viruses 253
Influenza immunology evaluation and correlates of protection: a focus on vaccines 251
Cell culture-derived influenza vaccines from Vero cells: a new horizon for vaccine production 249
Immunogenicity, safety and tolerability of inactivated trivalent influenza vaccine in overweight and obese children 239
Influenza D virus: Serological evidence in the Italian population from 2005 to 2017 233
Solubilization methods and reference 2-DE map of cow milk fat globules 229
Impact of erythrocyte species on assays for influenza serology 214
Exploring the implication of DDX3X in DENV infection: discovery of the first-in-class DDX3X fluorescent inhibitor 213
Measles in pregnancy: a threat for Italian women? 203
Retrospective Study Evaluating Seroprevalence of Hepatitis E Virus in Blood Donors and in Swine Veterinarians in Italy (2004) 198
Elettroforesi bidimensionale 197
Influenza vaccines: Evaluation of the safety profile 196
Overview of serological techniques for influenza vaccine evaluation: Past, Present and Future 189
System-oriented optimization of multi-target 2,6-diaminopurine derivatives: Easily accessible broad-spectrum antivirals active against flaviviruses, influenza virus and SARS-CoV-2 189
Recombinant Haemagglutinin Derived From the Ciliated Protozoan Tetrahymena thermophila Is Protective Against Influenza Infection 188
A serological investigation in Southern Italy: was SARS-CoV-2 circulating in late 2019? 186
Surveillance for severe acute respiratory infections among hospitalized subjects from 2015/2016 to 2019/2020 seasons in Tuscany, Italy 185
Expression of sialic acid influenza receptors in red blood cells from avian and mammalian species: an immunological comparative study 179
Evaluation of SARS‐CoV‐2 neutralizing antibodies using a CPE‐based colorimetric live virus micro‐neutralization assay in human serum samples 179
Evaluation of Monkeypox- and Vaccinia virus-neutralizing antibodies in human serum samples after vaccination and natural infection 173
Validation of Single Radial Haemolysis assay: A reliable method to measure antibodies against influenza viruses 173
Detection of antibodies against influenza D virus in swine veterinarians in Italy in 2004 169
Serologically-Based Evaluation of Cross-Protection Antibody Responses among Different A(H1N1) Influenza Strains 167
Water and air ozone treatment as an alternative sanitizing technology 166
SARS-CoV-2 and influenza virus coinfections in the Tuscan population during the 2021/2022 influenza season 165
Immune response to SARS-CoV-2 Omicron variant in patients and vaccinees following homologous and heterologous vaccinations 164
Antibody Avidity and Neutralizing Response against SARS-CoV-2 Omicron Variant after Infection or Vaccination 164
Comparative analyses of SARS-CoV-2 binding (IgG, IgM, IgA) and neutralizing antibodies from human serum samples 163
Immunoproteomics of myasthenia 163
Medicine use and recurrent complaints among 15-years-old adolescents in Tuscany 162
Immunity to measles in Italian children and adolescents: a persistent problem in view of measles elimination 162
Evaluating influenza vaccines: Progress and perspectives 160
Evaluation of maternal perception of children's weight and body mass index in tuscany, Italy 160
Immunogenicity and safety of COVID-19 booster vaccination: A population-based clinical trial to identify the best vaccination strategy 153
COVID-19 Outbreak and BNT162b2 mRNA Vaccination Coverage in a Correctional Facility during Circulation of the SARS-CoV-2 Omicron BA.1 Variant in Italy 153
Is influenza A/H10N8 a potential candidate for the next pandemic? 153
Trend della prevalenza di sovrappeso e obesità nei bambini toscani in età scolare dal 2002 al 2016 [Trends of overweight and obesity prevalence among schoolchildren in Tuscany Region (Central Italy), period 2002-2016] 151
Trend of Correlations between Psychological Symptoms and Socioeconomic Inequalities among Italian Adolescents: Cross-Sectional Study from 2006 to 2018 in Tuscany Region 149
Improving the ONE HEALTH approach: a lesson from SARS-CoV-2 pandemic 148
There is a correlation between nutritional status, Self-Rated Health and Life Satisfaction? Evidence from 2018 Health Behaviour in School-aged Children cross sectional study in a sample of Italian adolescents living in Tuscany Region 146
Neutralizing activity of African lineage Zika virus immune sera towards Asian lineage 144
An external quality assessment feasibility study; cross laboratory comparison of haemagglutination inhibition assay and microneutralization assay performance for seasonal influenza serology testing: A FLUCOP study 143
Zika virus in west africa: A seroepidemiological study between 2007 and 2012 143
Effects of Influenza Vaccine on the Immune Responses to SARS-CoV-2 Vaccination 142
In Vitro Antiviral and Virucidal Activity of Ozone against Feline Calicivirus 139
Evaluation of varicella immunity during pregnancy in apulia region, southern italy 138
Characterization of antibody response in asymptomatic and symptomatic SARS-CoV-2 infection 137
Low prevalence of antibodies against pertussis in pregnant women in Italy 136
null 136
Evaluation of monkeypox‐ and vaccinia‐virus neutralizing antibodies before and after smallpox vaccination: A sero‐epidemiological study 132
Emerging and Re-emerging Arboviral Diseases as a Global Health Problem 132
Tecnologie per l'analisi del proteoma 128
Haemagglutination inhibition and virus microneutralisation serology assays: use of harmonised protocols and biological standards in seasonal influenza serology testing and their impact on inter-laboratory variation and assay correlation: A FLUCOP collaborative study 127
Detection of Influenza D Antibodies in Dogs, Apulia Region, Italy, 2016 and 2023 127
SARS-CoV-2 epidemiological trend before vaccination era: a seroprevalence study in Apulia, Southern Italy, in 2020 126
The neutralizing response to SARS-CoV-2 Omicron variants BA.1 and BA.2 in COVID-19 patients and homologous and heterologous vaccinees 125
Centenarians, semi and supercentenarians, COVID-19 and Spanish flu: a serological assessment to gain insight into the resilience of older centenarians to COVID-19 122
Serological Evidence for Circulation of Influenza D Virus in the Ovine Population in Italy 121
Correlation of Influenza B Haemagglutination Inhibiton, Single-Radial Haemolysis and Pseudotype-Based Microneutralisation Assays for Immunogenicity Testing of Seasonal Vaccines 121
Establishment and validation of a high-throughput micro-neutralization assay for respiratory syncytial virus (subtypes A and B) 119
Prevalence of Influenza B/Yamagata Viruses From Season 2012/2013 to 2021/2022 in Italy as an Indication of a Potential Lineage Extinction 119
Measles immunity over two decades in two large Italian Regions: How far is the elimination goal? 117
West Nile Virus Seroprevalence in the Italian Tuscany Region from 2016 to 2019 116
null 116
Serum neutralizing activity against b.1.1.7, b.1.351, and p.1 sars-cov-2 variants of concern in hospitalized covid-19 patients 116
Assessment of Pertussis Underreporting in Italy 113
Assay Harmonization and Use of Biological Standards To Improve the Reproducibility of the Hemagglutination Inhibition Assay: a FLUCOP Collaborative Study 112
Sorveglianza virologica della nuova variante del virus influenzale A/H1N1 nell’Area Vasta Toscana sud 112
Seroprevalence of hepatitis e virus in forestry workers from trentino-alto adige region (Northern Italy) 112
Detection of IgM, IgG and SARS-CoV-2 RNA among the personnel of the University of Milan, March through May 2020: The UNICORN study 108
Evaluation of antibody response to SARS-CoV-2 variants after 2 doses of mRNA COVID-19 vaccine in a correctional facility 106
Immunogenicity of Calvenza-03 EIV/EHV® Vaccine in Horses: Comparative In Vivo Study 104
Influenza Viruses and Vaccines: The Role of Vaccine Effectiveness Studies for Evaluation of the Benefits of Influenza Vaccines 103
The burden of influenza and the role of influenza vaccination in adults aged 50-64 years: A summary of available evidence 103
Evaluation of immune response to SARS-CoV-2 Omicron sublineages six months after different vaccination regimens in Italy 103
Measles Susceptibility in Apulia: The Italian Mirror? 103
SARS-CoV-2 infection among asymptomatic homebound subjects in Milan, Italy 103
Assessing the virucidal activity of essential oils against feline calicivirus, a non-enveloped virus used as surrogate of norovirus 101
Flu vaccine administration in the period before SARS-CoV-2 infection and its outcomes: An umbrella review 100
Virucidal activity in vitro of mouthwashes against a feline coronavirus type II 97
Viricide activity of antimicrobial blue light (405 nm) against the SARS-CoV-2 and influenza virus 97
Virucidal Activity of Lemon Essential Oil against Feline Calicivirus Used as Surrogate for Norovirus 97
Analysis of the SARS-CoV-2 inactivation mechanism using violet-blue light (405 nm) 95
SARS-CoV-2 Circulation during the First Year of the Pandemic: A Seroprevalence Study from January to December 2020 in Tuscany, Italy 88
Validation of a Harmonized Enzyme-Linked-Lectin-Assay (ELLA-NI) Based Neuraminidase Inhibition Assay Standard Operating Procedure (SOP) for Quantification of N1 Influenza Antibodies and the Use of a Calibrator to Improve the Reproducibility of the ELLA-NI With Reverse Genetics Viral and Recombinant Neuraminidase Antigens: A FLUCOP Collaborative Study 87
In vitro virucidal activity of mouthwashes on SARS-CoV-2 87
The baculovirus expression vector system: a modern technology for the future of influenza vaccine manufacturing 86
Totale 18.243
Categoria #
all - tutte 55.612
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.612


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021715 0 0 0 0 0 0 0 0 0 299 172 244
2021/20221.116 135 177 143 98 49 35 52 37 61 78 95 156
2022/20231.154 67 144 137 144 100 207 44 101 123 32 33 22
2023/20241.134 36 42 90 45 42 251 437 21 13 53 15 89
2024/20253.228 62 227 301 218 366 223 106 162 317 127 315 804
2025/20267.392 620 916 1.261 1.035 1.363 320 825 255 371 426 0 0
Totale 19.019